logo

For the Inventor, By the Inventor

Nishinomiya, Japan

Akira Imada

This inventor holds 6 USPTO granted patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1978-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Imada. Retrieved from https://idiyas.com/inventor/akira-imada-zoi7ly0d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 33(Granted Patents)


Location History:

  • Nishinomiya, JA (1978)
  • Nishinomiya, JP (1980 - 1985)
  • Hyogo, JP (1985)

Company Filing History:

goldMedal6 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents

Years Active: 1978-1985

Loading Chart...
6 patents (USPTO):Explore Patents
1. 4518529 - Antibiotics C-19393S.sub.2 (1985-05-21),
2. 4504655 - Substances potentiating the activity of antibiotics and their production (1985-03-12),
3. 4409147 - Carbapenem compounds and their production (1983-10-11),
4. 4229436 - Antibiotic G-6302 (1980-10-21),
5. 4225586 - Antibiotic SB-72310 (1980-09-30),
6. 4069316 - Method for producing antibiotic T-42082 and antibiotic T-42082 (1978-01-17),

Title: Akira Imada: Innovator in Antibiotic Development

Introduction

Akira Imada is a notable inventor based in Nishinomiya, Japan. He has made significant contributions to the field of antibiotics, holding a total of 6 patents. His work focuses on developing novel compounds that enhance the effectiveness of existing antibiotic treatments.

Latest Patents

Among his latest patents are the Antibiotics C-19393S.sub.2 and H.sub.2. These novel antibiotics are produced by cultivating a microorganism belonging to the genus Streptomyces. They are particularly useful as bactericides or disinfectants. Notably, Antibiotic C-19393S.sub.2 produces a synergistic effect when used in conjunction with penicillin and/or cephalosporin antibiotic agents. Another significant patent involves substances that potentiate the activity of antibiotics. This novel compound has a specific formula that enhances the antibacterial activity of .beta.-lactam antibiotics, making it valuable for treating infectious diseases in mammals and domestic fowls.

Career Highlights

Akira Imada is currently associated with Takeda Chemical Industries, Inc., a leading company in the pharmaceutical sector. His innovative work has positioned him as a key figure in antibiotic research and development.

Collaborations

Throughout his career, Akira has collaborated with several talented individuals, including Mitsuko Asai and Kazuhiko Kintaka. These collaborations have further enriched his research and contributed to the advancement of antibiotic therapies.

Conclusion

Akira Imada's contributions to antibiotic development are noteworthy and impactful. His innovative patents and collaborations continue to influence the field of medicine, particularly in the fight against bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…